Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports changes in beneficial ownership due to shares withheld by the issuer to cover tax obligations related to vesting restricted stock units.
Summary
- On July 31, 2024, Eric Sievers, the Chief Medical Officer of BioAtla, Inc., had 572 shares of common stock withheld by the issuer to cover income tax obligations.
- The shares were withheld in connection with the vesting and net settlement of previously reported restricted stock units.
- The price per share for the transaction was $1.81.
- Following the transaction, Sievers beneficially owns 208,134 shares of BioAtla, Inc.
- The transaction was reported on August 1, 2024.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock ownership and tax obligations, and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report changes in their ownership of company stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of transaction where shares were withheld for tax obligations. |
| 08/01/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.